| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 0121 |
|
281 |
277 |
$5.12M |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
11,900 |
11,003 |
$4.71M |
| 0122 |
|
56 |
56 |
$1.02M |
| Z7502 |
|
24,161 |
23,213 |
$900K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
12,858 |
11,210 |
$849K |
| 99199 |
Unlisted special service, procedure or report |
16,180 |
13,540 |
$810K |
| 0450 |
Emergency room services |
14,276 |
12,589 |
$635K |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,363 |
3,264 |
$563K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
10,988 |
10,642 |
$555K |
| 87486 |
|
11,398 |
11,048 |
$521K |
| 87581 |
|
11,402 |
11,051 |
$508K |
| 80053 |
Comprehensive metabolic panel |
37,268 |
34,329 |
$477K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
38,745 |
35,453 |
$358K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,370 |
1,351 |
$283K |
| 84443 |
Thyroid stimulating hormone (TSH) |
12,539 |
12,207 |
$276K |
| T1999 |
Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" |
18,544 |
9,579 |
$211K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,630 |
2,467 |
$204K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,991 |
1,943 |
$201K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
9,017 |
8,356 |
$198K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
3,899 |
3,795 |
$183K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
3,899 |
3,795 |
$181K |
| Z7610 |
|
14,726 |
10,355 |
$181K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
6,258 |
6,226 |
$180K |
| 80061 |
Lipid panel |
10,385 |
10,304 |
$170K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
7,704 |
1,649 |
$158K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,255 |
1,255 |
$146K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,862 |
2,762 |
$133K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
2,204 |
2,080 |
$130K |
| 71045 |
Radiologic examination, chest; single view |
8,841 |
8,380 |
$126K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,443 |
1,363 |
$126K |
| 99460 |
|
121 |
120 |
$125K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,049 |
976 |
$121K |
| 87631 |
|
1,995 |
1,962 |
$121K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
9,104 |
8,987 |
$117K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
510 |
505 |
$111K |
| 84439 |
|
8,694 |
8,583 |
$104K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,824 |
1,734 |
$101K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,427 |
1,070 |
$99K |
| 87507 |
|
212 |
208 |
$98K |
| 83690 |
|
11,307 |
10,567 |
$92K |
| 83880 |
|
3,241 |
3,047 |
$92K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,327 |
1,310 |
$92K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,289 |
1,225 |
$89K |
| 76830 |
Ultrasound, transvaginal |
1,106 |
1,089 |
$77K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,209 |
1,168 |
$76K |
| 84484 |
|
6,730 |
6,317 |
$73K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
827 |
813 |
$70K |
| 97139 |
|
3,041 |
550 |
$66K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,371 |
1,344 |
$65K |
| 71250 |
|
230 |
228 |
$61K |
| 59409 |
Vaginal delivery only (with or without episiotomy and/or forceps) |
114 |
112 |
$60K |
| 80150 |
|
3,587 |
3,245 |
$55K |
| 81025 |
|
6,667 |
6,270 |
$50K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
551 |
551 |
$50K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,586 |
1,496 |
$49K |
| 76801 |
|
891 |
818 |
$47K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
2,110 |
2,011 |
$47K |
| 94664 |
|
3,229 |
2,807 |
$46K |
| 84145 |
|
2,182 |
2,089 |
$45K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
5,715 |
5,323 |
$43K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,162 |
1,162 |
$43K |
| 80055 |
|
722 |
722 |
$42K |
| 82542 |
|
1,698 |
1,603 |
$41K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,424 |
2,331 |
$40K |
| 86803 |
|
1,843 |
1,836 |
$37K |
| 81001 |
|
9,157 |
8,581 |
$36K |
| 81003 |
|
11,718 |
10,879 |
$30K |
| 83605 |
|
2,197 |
2,096 |
$26K |
| 86140 |
|
4,096 |
3,944 |
$26K |
| 71046 |
Radiologic examination, chest; 2 views |
1,086 |
1,056 |
$25K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
524 |
222 |
$25K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
352 |
339 |
$24K |
| 59025 |
Fetal non-stress test |
864 |
544 |
$23K |
| 99223 |
Prolong inpt eval add15 m |
305 |
298 |
$22K |
| 82728 |
|
1,614 |
1,599 |
$22K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,785 |
3,572 |
$21K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
25 |
25 |
$21K |
| 36415 |
Collection of venous blood by venipuncture |
15,879 |
13,913 |
$20K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,028 |
972 |
$20K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,823 |
3,652 |
$20K |
| 99233 |
Prolong inpt eval add15 m |
466 |
155 |
$18K |
| 99243 |
|
244 |
244 |
$18K |
| 73610 |
|
601 |
570 |
$18K |
| 76536 |
|
233 |
233 |
$18K |
| 73630 |
|
671 |
641 |
$18K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
241 |
222 |
$17K |
| 72131 |
|
56 |
56 |
$17K |
| 73030 |
|
549 |
538 |
$17K |
| 81513 |
|
94 |
92 |
$16K |
| 80143 |
|
1,071 |
987 |
$16K |
| 83550 |
|
1,586 |
1,568 |
$16K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
242 |
205 |
$16K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
105 |
102 |
$16K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
308 |
302 |
$16K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
818 |
411 |
$15K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
356 |
349 |
$15K |
| 76770 |
|
139 |
138 |
$15K |
| 80179 |
|
978 |
897 |
$15K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
84 |
83 |
$15K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
25 |
25 |
$14K |
| 83540 |
|
1,713 |
1,692 |
$14K |
| 73562 |
|
495 |
487 |
$13K |
| 83735 |
|
1,708 |
1,577 |
$13K |
| 93307 |
|
168 |
125 |
$12K |
| 84702 |
|
1,136 |
934 |
$12K |
| J3490 |
Unclassified drugs |
464 |
129 |
$12K |
| 77066 |
Tomosynthesis, mammo |
78 |
78 |
$11K |
| 82043 |
|
1,350 |
1,344 |
$11K |
| 87186 |
|
1,707 |
1,644 |
$10K |
| 76982 |
|
112 |
112 |
$10K |
| 93971 |
|
64 |
63 |
$10K |
| 87040 |
|
953 |
924 |
$10K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,964 |
1,812 |
$9K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
958 |
791 |
$9K |
| 82607 |
|
805 |
803 |
$9K |
| 82746 |
|
425 |
421 |
$9K |
| 87077 |
|
1,922 |
1,857 |
$9K |
| 74018 |
|
415 |
394 |
$8K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
816 |
766 |
$8K |
| 85730 |
|
1,263 |
1,210 |
$8K |
| 73110 |
|
245 |
221 |
$8K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
517 |
486 |
$8K |
| 76642 |
|
132 |
131 |
$8K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
241 |
237 |
$7K |
| 73130 |
|
244 |
234 |
$7K |
| 0762 |
|
153 |
95 |
$7K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
46 |
45 |
$7K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
174 |
87 |
$7K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
1,287 |
828 |
$7K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
172 |
166 |
$6K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
264 |
256 |
$6K |
| 85651 |
|
1,341 |
1,312 |
$6K |
| 84436 |
|
664 |
622 |
$5K |
| 82550 |
|
793 |
750 |
$5K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
838 |
784 |
$5K |
| 87481 |
|
96 |
94 |
$5K |
| 85610 |
|
1,080 |
960 |
$5K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
934 |
850 |
$5K |
| 87420 |
|
425 |
420 |
$5K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
634 |
518 |
$5K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
38 |
24 |
$5K |
| 73700 |
|
13 |
13 |
$4K |
| 97161 |
|
81 |
80 |
$4K |
| 87081 |
|
457 |
455 |
$4K |
| 99000 |
|
1,210 |
1,189 |
$4K |
| 99222 |
Initial hospital care, per day, moderate complexity |
69 |
69 |
$4K |
| 97035 |
|
295 |
95 |
$4K |
| 93000 |
|
105 |
102 |
$4K |
| 0011A |
|
91 |
91 |
$4K |
| 72100 |
|
86 |
86 |
$4K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
108 |
108 |
$3K |
| J2060 |
Injection, lorazepam, 2 mg |
570 |
482 |
$3K |
| 97010 |
|
199 |
86 |
$3K |
| 0012A |
|
83 |
83 |
$3K |
| 84153 |
|
120 |
118 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
270 |
266 |
$3K |
| 86850 |
|
239 |
225 |
$3K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
132 |
56 |
$3K |
| 0160 |
|
48 |
31 |
$3K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
100 |
99 |
$3K |
| 87070 |
|
231 |
228 |
$3K |
| 76641 |
|
44 |
44 |
$3K |
| 86592 |
|
515 |
510 |
$3K |
| 82950 |
|
381 |
380 |
$2K |
| 80299 |
|
151 |
125 |
$2K |
| 73560 |
|
93 |
90 |
$2K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
70 |
63 |
$2K |
| 90715 |
|
38 |
38 |
$2K |
| 73564 |
|
57 |
57 |
$2K |
| 99462 |
|
67 |
49 |
$2K |
| 82150 |
|
209 |
204 |
$2K |
| 96367 |
|
38 |
38 |
$2K |
| 73502 |
|
38 |
38 |
$2K |
| 87634 |
|
29 |
29 |
$2K |
| 0270 |
|
766 |
462 |
$2K |
| 73080 |
|
42 |
37 |
$1K |
| 97014 |
|
75 |
27 |
$1K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
117 |
113 |
$1K |
| 73140 |
|
62 |
57 |
$1K |
| 0721 |
|
65 |
51 |
$1K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
29 |
29 |
$1K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
95 |
93 |
$1K |
| 0004A |
|
29 |
29 |
$1K |
| 82140 |
|
77 |
72 |
$1K |
| 0064A |
|
26 |
26 |
$1K |
| 86308 |
|
137 |
135 |
$1K |
| Z7500 |
|
29 |
26 |
$988.90 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
51 |
36 |
$977.54 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
23 |
22 |
$970.05 |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
12 |
12 |
$969.36 |
| 97535 |
Self-care/home management training, each 15 minutes |
41 |
31 |
$950.38 |
| 72110 |
|
13 |
13 |
$933.17 |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
12 |
12 |
$900.82 |
| 82570 |
|
105 |
103 |
$827.59 |
| 83970 |
|
13 |
13 |
$821.08 |
| 85044 |
|
117 |
114 |
$771.03 |
| 84550 |
|
128 |
113 |
$751.72 |
| 84100 |
|
105 |
104 |
$717.75 |
| 85027 |
|
74 |
74 |
$693.00 |
| 87641 |
|
14 |
14 |
$661.50 |
| 84156 |
|
129 |
124 |
$640.35 |
| 85378 |
|
40 |
39 |
$553.15 |
| 82977 |
|
58 |
57 |
$542.70 |
| 0071A |
|
13 |
13 |
$520.00 |
| 0002A |
|
13 |
13 |
$520.00 |
| J2704 |
Injection, propofol, 10 mg |
130 |
92 |
$515.89 |
| 84460 |
|
68 |
61 |
$486.60 |
| X3910 |
|
47 |
12 |
$462.48 |
| 99001 |
|
2,394 |
2,329 |
$438.02 |
| 93225 |
|
12 |
12 |
$414.15 |
| 82947 |
|
69 |
65 |
$297.91 |
| 87071 |
|
40 |
39 |
$279.65 |
| 81002 |
|
141 |
63 |
$278.21 |
| 86430 |
|
29 |
29 |
$262.92 |
| 82010 |
|
28 |
27 |
$237.29 |
| 82951 |
|
12 |
12 |
$236.28 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
41 |
41 |
$223.97 |
| 93244 |
|
12 |
12 |
$190.59 |
| 29515 |
|
14 |
14 |
$184.38 |
| 82247 |
|
21 |
14 |
$153.60 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
30 |
26 |
$149.45 |
| 96376 |
|
42 |
42 |
$135.30 |
| 82248 |
|
17 |
12 |
$130.56 |
| 0251 |
|
129 |
117 |
$94.30 |
| 0250 |
|
188 |
178 |
$92.90 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
12 |
12 |
$82.08 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
12 |
12 |
$67.06 |
| 0300 |
|
437 |
427 |
$50.26 |
| 96379 |
|
314 |
206 |
$24.00 |
| A9270 |
Non-covered item or service |
345 |
284 |
$16.20 |
| 0306 |
|
213 |
207 |
$15.23 |
| 0258 |
|
437 |
421 |
$11.78 |
| 0636 |
|
325 |
317 |
$9.74 |
| 0301 |
|
311 |
304 |
$9.65 |
| 0637 |
|
51 |
51 |
$5.40 |
| 0305 |
|
401 |
395 |
$4.97 |
| 81015 |
|
44 |
42 |
$3.05 |
| 0307 |
|
212 |
206 |
$2.03 |
| 3074F |
|
124 |
114 |
$0.00 |
| 0259R |
|
159 |
152 |
$0.00 |
| 0271R |
|
111 |
109 |
$0.00 |
| 0324 |
|
96 |
95 |
$0.00 |
| 0720 |
|
13 |
13 |
$0.00 |
| 80320 |
|
30 |
25 |
$0.00 |
| 0352 |
|
70 |
69 |
$0.00 |
| 0250R |
|
173 |
159 |
$0.00 |
| 0302 |
|
316 |
310 |
$0.00 |
| 0258R |
|
53 |
51 |
$0.00 |
| 0272R |
|
228 |
214 |
$0.00 |
| 0730 |
|
97 |
93 |
$0.00 |
| 0460 |
|
90 |
88 |
$0.00 |
| 3078F |
|
133 |
124 |
$0.00 |
| 0470 |
|
27 |
26 |
$0.00 |
| 0252 |
|
38 |
38 |
$0.00 |
| 0412 |
|
14 |
13 |
$0.00 |
| 0272 |
|
14 |
14 |
$0.00 |